Literature DB >> 16162763

Deep venous thrombosis in patients with acute pulmonary embolism: prevalence, risk factors, and clinical significance.

Philippe Girard1, Olivier Sanchez, Christophe Leroyer, Dominique Musset, Guy Meyer, Jean-Baptiste Stern, Florence Parent.   

Abstract

STUDY
OBJECTIVES: To determine the prevalence of lower-limb deep venous thrombosis (DVT) that can be detected by compression ultrasonography (CUS) in patients with symptomatic pulmonary embolism (PE) diagnosed with spiral CT pulmonary angiography (CTPA); and to explore the risk factors for positive CUS results and the prognostic significance of such findings.
DESIGN: Post hoc analysis of data from a prospective multicenter outcome study of 1,041 patients with clinically suspected non-severe PE. All patients underwent CTPA and CUS within 24 h of enrollment and were followed up for 3 months. PATIENTS: Among the 290 patients with positive CT findings, CUS was diagnostic in 281 patients who constitute the study population.
RESULTS: Mean age +/- SD was 64.3 +/- 17.7 years; 128 patients (44.8%) were men. DVT signs or symptoms were present in 90 patients (32%). CUS detected DVT in 169 patients (60.1%; 95% confidence interval [CI], 54.1 to 65.9%), including 127 patients (45.2%; 95% CI, 39.3 to 51.2%) with proximal DVT. Sensitivity and specificity of DVT symptoms for CUS-detectable DVT were 43% and 85%, respectively. Multivariate analysis showed that an age > or = 70 years (odds ratio [OR], 1.90; 95% CI, 1.14 to 3.17) and the presence of DVT signs or symptoms (OR, 4.12; 95% CI, 2.24 to 7.55) were independent risk factors for positive CUS results. DVT symptoms (OR, 4.78; 95% CI, 2.75 to 8.33) and a history of venous thromboembolism (OR, 2.59; 95% CI, 1.46 to 4.62) were independent risk factors for proximal DVT. The 3-month risk of recurrent thromboembolic event or death was not significantly different among patients with and without DVT (6.5% vs 2.7%, p = 0.15).
CONCLUSION: These results do not support screening for DVT in patients with CTPA-proven symptomatic PE; however, they suggest that CUS might prove especially efficient and safe as a frontline test in elderly patients with suspected PE. Further studies are needed before these conclusions can be translated into clinical recommendations.

Entities:  

Mesh:

Year:  2005        PMID: 16162763     DOI: 10.1378/chest.128.3.1593

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique.

Authors:  Kirsten van Langevelde; Alexandr Srámek; Patrice W J Vincken; Jan-Kees van Rooden; Frits R Rosendaal; Suzanne C Cannegieter
Journal:  Haematologica       Date:  2012-07-16       Impact factor: 9.941

2.  Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms.

Authors:  Ram S Duriseti; Margaret L Brandeau
Journal:  Ann Emerg Med       Date:  2010-06-03       Impact factor: 5.721

3.  Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication.

Authors:  Rakhi P Naik; Michael B Streiff; Carlton Haywood; Julie A Nelson; Sophie Lanzkron
Journal:  Am J Med       Date:  2013-05       Impact factor: 4.965

4.  Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study.

Authors:  P L Lutsey; F L Norby; A Alonso; M Cushman; L Y Chen; E D Michos; A R Folsom
Journal:  J Thromb Haemost       Date:  2018-03-13       Impact factor: 5.824

5.  Atrial fibrillation is related to lower incidence of deep venous thrombosis in patients with pulmonary embolism.

Authors:  Khalid Bin Waleed; Xumin Guan; Xintao Li; Yiheng Yang; Zhao Wang; Xiaomeng Yin; Zhengyan Wang; Jianghai Liu; Lianjun Gao; Dong Chang; Xianjie Xiao; Rongfeng Zhang; Gary Tse; Yunlong Xia
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

6.  Value of venous color flow duplex scan as initial screening test for geriatric inpatients with clinically suspected pulmonary embolism.

Authors:  Raghid Kreidy; Elias Stephan; Pascale Salameh; Mirna Waked
Journal:  Vasc Health Risk Manag       Date:  2011-09-15

7.  Prognosis of patients with suspected pulmonary embolism in Buenos Aires: a prospective cohort study.

Authors:  Fernando Javier Vazquez; María Lourdes Posadas-Martínez; Fernán González Bernaldo de Quirós; Diego Hernan Giunta
Journal:  BMC Pulm Med       Date:  2014-12-15       Impact factor: 3.317

8.  Deep Vein Thrombosis in Patients with Pulmonary Embolism: Prevalance, Clinical Significance and Outcome.

Authors:  Jun Sung Lee; Tong Moon; Tae Hoon Kim; Se Young Kim; Jun Young Choi; Kyung Bok Lee; Yu Jin Kwon; Suk Hee Song; Su Hyun Kim; Hae Ok Kim; Ho Kyeong Hwang; Min Ji Kim; Young Kyoung Lee
Journal:  Vasc Specialist Int       Date:  2016-12-31

9.  Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort.

Authors:  Fernando Javier Vázquez; María Lourdes Posadas-Martínez; Jimena Vicens; Fernán González Bernaldo de Quirós; Diego Hernán Giunta
Journal:  Thromb J       Date:  2013-08-01

10.  Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.

Authors:  Erin M Hald; Ludvig B Rinde; Maja-Lisa Løchen; Ellisiv B Mathiesen; Tom Wilsgaard; Inger Njølstad; Sigrid K Brækkan; John-Bjarne Hansen
Journal:  J Am Heart Assoc       Date:  2018-01-29       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.